Olarte, Alicent Kaori M.

HRN: 24-86-96  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/04/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
06/04/2025
06/10/2025
ORAL
3ml
Q8
Intestinal Amoebiasis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines